<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01574586</url>
  </required_header>
  <id_info>
    <org_study_id>BEGIN12</org_study_id>
    <nct_id>NCT01574586</nct_id>
  </id_info>
  <brief_title>Bifurcation Stenting Using 2 Link Stent Nobori Versus 3 Link Stent Xience</brief_title>
  <acronym>BEGIN</acronym>
  <official_title>A Multicenter, Randomized Trial to Compare 2 Link Nobori and 3 Link Xience Stents in Bifurcation Stenting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kurashiki Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kurashiki Central Hospital</source>
  <brief_summary>
    <textblock>
      The primary objective of this study is to make a comparison of safety and efficacy of DESs
      with different link number (2-link Nobori and 3-link Xience) in patients with de novo true
      bifurcation lesions.

      The minimum lumen diameter of the side branch ostium in bifurcation at 8 months and the MACE
      rate until one year after PCI will be assessed in both groups.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Actual">May 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Minimum lumen diameter of the side branch ostium in bifurcation</measure>
    <time_frame>8 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of MACE</measure>
    <time_frame>in-hospital, 30 days, 8 months, 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Coronary Stenosis</condition>
  <arm_group>
    <arm_group_label>2-link stent Nobori</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bifurcation stenting</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3-link stent Xience</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Bifurcation stenting</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Bifurcation stenting</intervention_name>
    <description>Bifurcation stenting using 2-link stent Nobori versus 3-link stent Xience</description>
    <arm_group_label>2-link stent Nobori</arm_group_label>
    <arm_group_label>3-link stent Xience</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient eligible for percutaneous coronary intervention

          2. Patient or substitute decision-maker willing to provide written informed consent,
             which is approved by the Institutional Review Board or its equivalence

          3. De novo stenosis at coronary bifurcation with up to two vessels (visually estimated
             diameter stenosis ≥50%)

          4. Second vessel at coronary bifurcation treatable with trial device during the procedure

          5. True coronary bifurcation, ≥50% diameter stenosis in both the main and side branches,
             belonging to the Medina classes 1.1.1, 1.0.1, and 0.1.1,

          6. Visually estimated target lesion reference vessel diameter, 2.5-5.0 mm in the main
             branch, ≥2.25 mm in the side branch

          7. Target lesion treatable with one or two stents in both the main and side branches

          8. Consensus of PCI after discussion between cardiologists and cardiac surgeons for the
             lesion in the left main coronary artery

          9. Thrombolysis in Myocardial Infarction grade ≥1 flow in both the main and side branches

        Exclusion Criteria:

        A. General restrictions

          1. Unable to be followed by the implementing medial institution

          2. Life expectancy &lt;1 year

          3. Acute myocardial infarction (&lt;1 week)

          4. Left ventricular ejection fraction &lt;30%

          5. Scheduled for elective treatment requiring antiplatelet drug Withdrawal

          6. Deemed as unsuitable by the investigator or subinvestigator

          7. Serum creatinine level ≥2.0 Mg/dl

        B. Vascular morphological restrictions

          1. Lesion proximal to coronary artery bypass graft anastomotic site (visual estimation
             ≤5.0 mm) or including a part of coronary artery bypass grafting

          2. In-stent restenosis

          3. Severe calcification
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kurashiki Central Hospital</name>
      <address>
        <city>Kurashiki</city>
        <zip>710-8602</zip>
        <country>Japan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>April 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 6, 2012</study_first_submitted>
  <study_first_submitted_qc>April 6, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2012</study_first_posted>
  <last_update_submitted>April 6, 2015</last_update_submitted>
  <last_update_submitted_qc>April 6, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>True Bifurcation stenosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

